In this commentary article from Colorectal Cancer the authors highlight the importance of considering BRAF-mutations when formulating treatment strategies for metastatic colorectal cancer.
Browsing: Journals > Colorectal Cancer
In this Perspective from Colorectal Cancer, the authors discuss the rising treatment costs in colorectal cancer, particularly in light of the availability of expensive targeted drugs.
Following the launch of a nationwide colorectal cancer screening program in The Netherlands in 2014, this Special Report discusses the various screening modalities studied and the lessons learnt so far from the scheme.
This article reviews the emerging usage of molecular markers for evaluating tumor staging and potential responses to pharmacological interventions.
This article considers the unique clinical challenge of treating patients with Lynch syndrome and rectal cancer, debating the factors mitigating surgical decisions.
Recognized as a subset of the disease with unique clinical and histopathologic characteristics, this article discusses the clinical implications of BRAF mutation-positive colorectal cancer.
Marwan Fakih, Professor at the City of Hope Comprehensive Cancer Center (CA, USA), discusses recent colorectal cancer research and the continuation towards precision medicine in the disease.
This review article discusses how we might determine the optimum neoadjuvant chemoradiotherapy regimen for patients with rectal cancer.
Why do we keep searching for alternative treatment options for the already successful neoadjuvant approach in rectal cancer? What are we looking for?